Patents by Inventor Birgit Hutter-Paier

Birgit Hutter-Paier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260092039
    Abstract: Compounds (I) are provided, where R1 and R2 are H or (C1-C3)-alkyl; X is a linear methylene chain of formula —[CH2]n— with n=0, 1 or 2, or a biradical from a branched saturated (C2-C4)-alkylene chain; and A is either a C-radical from a non-aromatic polycyclic 6- to 15-membered carbocyclic ring system, or a C-radical from a polycyclic 6- to 15-membered heterocyclic ring system having one or two O, S or N; wherein the C-radicals are unsubstituted or substituted. Compounds (I) are simultaneously inhibitors of soluble epoxide hydrolase and inhibitors of glutaminyl cyclase. Besides, they reduce the levels of pro-inflammatory cytokines in LPS stimulated BV2 cells, display low cytotoxicity, and have good BBB permeability. Thus, they are useful as multitarget compounds for the prevention or treatment of Alzheimer's disease.
    Type: Application
    Filed: March 4, 2024
    Publication date: April 2, 2026
    Inventors: Diego MUÑOZ-TORRERO LÓPEZ-IBARRA, Santiago VÁZQUEZ CRUZ, Noemí MARTÍNEZ CONDE, Eugènia-Alexandra PUJOL BECH, Tina LÖFFLER, Daniela BRUNNER, Manuela PROKESCH, Roland RABL, Birgit HUTTER-PAIER
  • Patent number: 7915220
    Abstract: A peptidomimetic agent from dextrorotatory amino acids includes vGek with Dval-gly-Dglu-Dlys as a central D-amino acid sequence, whereby gly is equal to D-glycine, which is equal to L-glycine. Pharmaceutical agents for use in the treatment of neurodegenerative diseases, in particular Alzheimer's disease, Parkinson's disease, Lewy Body dementia, Creutzfeldt-Jakob disease, as well as Huntington's Chorea disease, multi-system atrophy as well as disorders similar to these neurodegenerative diseases that contain at least one peptidomimetic agent from dextrorotatory amino acids are also included.
    Type: Grant
    Filed: April 14, 2008
    Date of Patent: March 29, 2011
    Assignee: JSW-Research Forschungslabor GmbH
    Inventors: Manfred Windisch, Birgit Hutter-Paier, Robert Wronski
  • Publication number: 20080200397
    Abstract: A peptidomimetic agent from dextrorotatory amino acids includes vGek with Dval-gly-Dglu-Dlys as a central D-amino acid sequence, whereby gly is equal to D-glycine, which is equal to L-glycine. Pharmaceutical agents for use in the treatment of neurodegenerative diseases, in particular Alzheimer's disease, Parkinson's disease, Lewy Body dementia, Creutzfeldt-Jakob disease, as well as Huntington's Chorea disease, multi-system atrophy as well as disorders similar to these neurodegenerative diseases that contain at least one peptidomimetic agent from dextrorotatory amino acids are also included.
    Type: Application
    Filed: April 14, 2008
    Publication date: August 21, 2008
    Applicant: JSW-RESEAECH FORSCHUNGSLABOR GMBH
    Inventors: Manfred Windisch, Birgit Hutter-Paier, Robert Wronski